Date: August 15, 2026
Board Meeting Outcomes
Disinvestment / Strategic Actions
Nature of Entity: RPG Active Pharma Limited ('RPGAP') is a wholly owned subsidiary of RPG Life Sciences Limited.
Investment Details:
- Investment Amount: ₹65,68,60,500
- Number of Shares: 21,89,535 equity shares
- Face Value: Re. 1/- each fully paid up
- Form of Consideration: Cash consideration by way of remittance through normal banking channel
Shareholding Impact: The Company's shareholding post this investment remains 100%.
Completion Status: The 21,89,535 equity shares were allotted on August 14, 2026, to the Company by RPGAP, completing the acquisition.
Strategic Rationale: The investment is in the equity shares of a wholly owned subsidiary to support its operations.
Background of Acquired Entity
RPG Active Pharma Limited:
- Incorporated: December 24, 2025
- Industry: Pharmaceutical Industry
- Status: Yet to commence operations
- Turnover: No turnover (pre-operational)
- Paid-up Capital: Rs. 1,16,85,000 (Rupees One Crore Sixteen Lakhs and Eight-Five Thousand only)